Dr Jeff Stark: Patients With Hidradenitis Suppurativa Have Improved Pain Management With Bimekizumab

Jeff Stark, MD, vice president and head of immunology, UCB, discusses findings on improved pain management in patients with moderate to severe hidradenitis suppurativa (HS).

Related Keywords

,Jeff Stark ,Hidradenitis Suppurativa ,